BBOT Technical

Technical Sentiment Analysis for BridgeBio Oncology Therapeutics Inc (BBOT) As of 2026-07-08, BridgeBio Oncology Therapeutics Inc (BBOT) is exhibiting a Buy technical sentiment. Our proprietary analysis, which aggregates 13 technical signals, shows that 8 indicators are flashing buy, while 5 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for BBOT stands at 65.41, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.0662, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 80.042 and the Commodity Channel Index (CCI) at 293.574 further confirm a 1.52 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, BBOT is trading below its 60-day moving average of $8.3 and below its 200-day long-term moving average of $10.411. Key price levels to watch include the immediate resistance at $9.173 and strong support at $7.003. A break above $9.173 could signal a bull continuation, while falling below $7.003 may test the next Fibonacci floor at $6.061.